Literature DB >> 24951840

Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.

Eric I Benchimol1, David R Mack2, Geoffrey C Nguyen3, Scott B Snapper4, Wenbin Li5, Nassim Mojaverian5, Pauline Quach6, Aleixo M Muise7.   

Abstract

BACKGROUND & AIMS: The Paris pediatric modification of the Montreal classification defines very early onset inflammatory bowel disease (VEO-IBD) as a form of IBD distinct from that of older children. We compared the incidence and outcomes of VEO-IBD with those of IBD in older children.
METHODS: We performed a population-based retrospective cohort study of all children diagnosed with IBD in Ontario, Canada, from 1994 through 2009. Trends in standardized incidence were calculated using Poisson regression. We compared outpatient and emergency department visits, hospitalizations, and surgeries among children diagnosed with IBD when they were younger than age 6, ages 6-9.9, and older than age 10 years. Multivariable models were adjusted for income and stratified by sex.
RESULTS: The incidence of IBD increased from 9.4 per 100,000 children (95% confidence interval [CI], 8.2-10.8/100,000 children) in 1994 to 13.2 per 100,000 children (95% CI, 11.9-14.6/100,000 children) in 2009 (P < .0001). The incidence increased by 7.4% per year among children younger than 6 years old and 6-9.9 years old, and by 2.2% per year among children ≥10 years old. IBD-related outpatient visits were less frequent among children <6 years old than ≥10 years old (odds ratio for female patients, 0.67; 95% CI, 0.58-0.78; odds ratio for male patients, 0.86; 95% CI, 0.75-0.98). Hazard ratios [HRs] for hospitalization were lower for children <6 years old (female HR, 0.70; 95% CI, 0.56-0.87; male HR, 1.12; 95% CI, 0.94-1.33) than for older children. HRs for surgery among children <6 years old with Crohn's disease were 0.35 for female patients (95% CI, 0.16-0.78) and 0.59 for male patients (95% CI, 0.34-0.99). HRs for children <6 years old with ulcerative colitis were 0.88 for female patients (95% CI, 0.47-1.63) and 0.42 for male patients (95% CI, 0.21-0.85). There was no difference in hospitalization or surgery rates among children 6-9.9 years old vs those ≥10 years old.
CONCLUSIONS: Based on a retrospective cohort study, the incidence of VEO-IBD increased from 1994 through 2009. Children diagnosed with IBD before they were 6 years old used fewer health services and had lower rates of surgery than children diagnosed when they were 10 years or older.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disease Progression; Epidemiology; Health Administrative Data; Pediatrics

Mesh:

Year:  2014        PMID: 24951840     DOI: 10.1053/j.gastro.2014.06.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  64 in total

1.  Prospective cohort study of ultrasound-ultrasound and ultrasound-MR enterography agreement in the evaluation of pediatric small bowel Crohn disease.

Authors:  Jonathan R Dillman; Ethan A Smith; Ramon Sanchez; Michael A DiPietro; Soudabeh Fazeli Dehkordy; Jeremy Adler; Vera DeMatos-Maillard; Shokoufeh Khalatbari; Matthew S Davenport
Journal:  Pediatr Radiol       Date:  2015-12-30

2.  A baseline assessment of enhanced recovery protocol implementation at pediatric surgery practices performing inflammatory bowel disease operations.

Authors:  Jonathan Vacek; Teaniese Davis; Benjamin T Many; Sharron Close; Sarah Blake; Yue-Yung Hu; Jane L Holl; Julie Johnson; Jennifer Strople; Mehul V Raval
Journal:  J Pediatr Surg       Date:  2020-06-27       Impact factor: 2.545

Review 3.  Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.

Authors:  Nicholas Carman; David R Mack; Eric I Benchimol
Journal:  Curr Gastroenterol Rep       Date:  2018-04-05

4.  The impact of perianal disease in young patients with inflammatory bowel disease.

Authors:  Nathan P Zwintscher; Puja M Shah; Amit Argawal; Patrick M Chesley; Eric K Johnson; Christopher R Newton; Justin A Maykel; Scott R Steele
Journal:  Int J Colorectal Dis       Date:  2015-05-21       Impact factor: 2.571

5.  Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablers.

Authors:  Johan Van Limbergen; Jennifer Haskett; Anne M Griffiths; Jeff Critch; Hien Huynh; Najma Ahmed; Jennifer C deBruyn; Robert Issenman; Wael El-Matary; Thomas D Walters; Cheryl Kluthe; Marie-Eve Roy; Elizabeth Sheppard; Wallace V Crandall; Stan Cohen; Frank M Ruemmele; Arie Levine; Anthony R Otley
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-15

Review 6.  Characterization of inflammatory bowel disease in elderly patients: A review of epidemiology, current practices and outcomes of current management strategies.

Authors:  Peter Stepaniuk; Charles N Bernstein; Laura E Targownik; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-12

Review 7.  Early-Onset Inflammatory Bowel Disease.

Authors:  Judith R Kelsen; Pierre Russo; Kathleen E Sullivan
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 8.  Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD.

Authors:  Anita Afzali; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2018-09

9.  Anatomical Road Mapping Using CT and MR Enterography for Ultrasound Molecular Imaging of Small Bowel Inflammation in Swine.

Authors:  Huaijun Wang; Stephen A Felt; Ismayil Guracar; Valentina Taviani; Jianhua Zhou; Rosa Maria Silveira Sigrist; Huiping Zhang; Joy Liau; José G Vilches-Moure; Lu Tian; Yamil Saenz; Thierry Bettinger; Brian A Hargreaves; Amelie M Lutz; Jürgen K Willmann
Journal:  Eur Radiol       Date:  2017-11-23       Impact factor: 5.315

10.  The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease.

Authors:  Judith R Kelsen; Maire A Conrad; Noor Dawany; Trusha Patel; Rawan Shraim; Audrey Merz; Kelly Maurer; Kathleen E Sullivan; Marcella Devoto
Journal:  Inflamm Bowel Dis       Date:  2020-05-12       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.